Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.
Clinical trials sponsored by Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd., explained in plain language.
-
New shot takes aim at stubborn high cholesterol
Disease control CompletedThis study tested a new injection called SYH2053 in 156 adults with high cholesterol. The goal was to see if it lowers bad cholesterol (LDL-C) better than a placebo or an existing treatment. Participants followed a low-fat diet and either took their usual cholesterol meds or none…
Phase: PHASE2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New schizophrenia drug injection shows promise in bioequivalence trial
Disease control CompletedThis study tested whether a new paliperidone palmitate injection works the same as the standard one in 256 Chinese patients with schizophrenia. Patients received either the new or the standard injection, and researchers measured drug levels in the blood to see if they matched. Th…
Phase: NA • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC